Statement Of Investor Complaints For The Quarter Ended March 31,2017
Statement of Investor Complaints for the quarter ended March 31,201710-04-2017
10-04-2017
Compliance Certificate Under The Half Year Ended March 31,2017
Pursuant to Regulation 7 (3) of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith attach the compliance report under requirements of sub-regulation (2) of Regulation 7 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended March 31,2017. Kindly take the same on your records10-04-2017
Shareholding for the Period Ended March 31, 2017
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here08-04-2017
Updates
It is hereby intimated to the Exchanges that the Nomination and Remuneration Committee of the Board of Directors of the Company has granted 2,88,500 stock options to twenty four employees of the Company under Caplin Point Employee Stock Option Plan -2015 at an exercise price of Rs.2/- each. The employees are eligible to exercise / subscribe for equivalent number of equity shares of the Company having the face value of Rs.2/- each....05-04-2017
Allotment of Equity Shares
Caplin Point Laboratories Ltd has informed BSE regarding "Allotment of Equity Shares".10-02-2017
Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016
Caplin Point Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Consolidated Financial Results for the period ended December 31, 20163. Standalone Limited Review for the period ended December 31, 20164. Consolidated Limited Review for the period ended December 31, 201606-02-2017
Board Meeting Intimation for Results & Closure of Trading Window
Caplin Point Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on February 06,2017 inter alia to consider, approve and take on record the Un-audited Financial Results for the quarter/nine months ended December 31,2016.Accordingly, the Trading Window for dealing in the equity shares of the Company will remain closed for Promoters, Directors, other Connected Persons and Employees...12-01-2017
Shareholding for the Period Ended December 31, 2016
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here09-01-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Caplin Point Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.06-01-2017
Updates
Caplin Point Laboratories Ltd has submitted to BSE a copy of brief profile of Mr. D. Sathayanarayanan, Additional Director.23-11-2016